↓ Skip to main content

Risperidone versus olanzapine for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, April 2006
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
6 tweeters

Citations

dimensions_citation
48 Dimensions

Readers on

mendeley
114 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Risperidone versus olanzapine for schizophrenia
Published in
Cochrane database of systematic reviews, April 2006
DOI 10.1002/14651858.cd005237.pub2
Pubmed ID
Authors

Mahesh B Jayaram, Prakash Hosalli, T S Stroup

Abstract

Antipsychotic medication is a mainstay of treatment for schizophrenia. Risperidone and olanzapine are popular choices among the new generation drugs.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 114 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 <1%
United Kingdom 1 <1%
Ireland 1 <1%
United States 1 <1%
Canada 1 <1%
Unknown 109 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 26 23%
Researcher 16 14%
Student > Ph. D. Student 12 11%
Other 12 11%
Student > Bachelor 9 8%
Other 39 34%
Readers by discipline Count As %
Medicine and Dentistry 44 39%
Psychology 18 16%
Unspecified 17 15%
Nursing and Health Professions 10 9%
Pharmacology, Toxicology and Pharmaceutical Science 9 8%
Other 16 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 November 2017.
All research outputs
#6,403,433
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#6,533
of 8,923 outputs
Outputs of similar age
#59,734
of 159,646 outputs
Outputs of similar age from Cochrane database of systematic reviews
#63
of 100 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. This one is in the 48th percentile – i.e., 48% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 159,646 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 100 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.